°øÁö»çÇ×

³»¿ëºÐ·ù ÃÊû¼¼¹Ì³ª
°Ô½ÃÀÚ PGRC ()
Á¦¸ñ [20240419] ÃÊû¼¼¹Ì³ª (Àå¼ºÈÆ¹Ú»ç, Elevar Therapeutics)
ÂüÁ¶URL  ÂüÁ¶URL Á¤º¸¾øÀ½.
ÂüÁ¶ÆÄÀÏ  ÆÄÀϾøÀ½
³»¿ë
´ÙÀ½°ú °°ÀÌ ÃÊû¼¼¹Ì³ª(WebEx °­ÀÇ)°¡ ÀÖÀ¸´Ï ±³½Ç ±¸¼º¿ø ¿©·¯ºÐµéÀÇ ¸¹Àº Âü¼® ¹Ù¶ø´Ï´Ù.

1.¿¬ Á¦ : Development of Rivoceranib in combination with Camrelizumab for the treatment of unresectable Hepatocellular Carcinoma

2.¿¬ ÀÚ : Àå¼ºÈÆ ¹Ú»ç (Elevar Therapeutics)

3.ÀÏ ½Ã : 2024³â 04¿ù 19ÀÏ(±Ý) 16:00~ [Webex¹ÌÆÃ µ¿½ÃÁøÇà]

4.Àå ¼Ò : Àǰú´ëÇÐ 6Ãþ ¾à¹°À¯Àüü¿¬±¸¼¾ÅÍ ¼¼¹Ì³ª½Ç